Across TCGA pan-cancer cohorts, OR7E101P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR7E101P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where OR7E101P RNA is repressed in tumor relative to normal tissue. In most cancer types OR7E101P is over-expressed in tumor, although a few such as BRCA and BLCA show the opposite, repressed pattern.

BRCA and BLCA are the cancer types where OR7E101P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7E101P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	−0.775	<.001	8	view →
BLCA	All	All	−0.155	.011	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: OR7E101P RNA expression & survival · all OR7E101P data types